Kawaguchi, Tsukasa <br/><br/>
Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma.  [electronic resource] 

 -  Hepatology research : the official journal of the Japan Society of Hepatology  Sep 2015 
 - 1023-1033 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1386-6346 
<br/><br/><label>Standard No.: </label>10.1111/hepr.12434  doi